Effect of ursodeoxycholic acid on copper induced oxidation of low density lipoprotein. 2005

A Geetha, and R Surendran
Post Graduate Department of Biochemistry, Bharathi Women's College, North Chennai, Tamil Nadu, India. geethav21@hotmail.com

The aim of this study was to investigate copper (Cu++) induced oxidation state of LDL isolated from obstructive jaundice (OBJ) patients with hyperlipidemia and the effect of UDCA on the same. LDL was isolated and oxidation was induced by 5 mM CuSO4 with/without UDCA at different concentrations. LDL oxidation was assessed at different time intervals in terms of conjugated dienes, hydroperoxides and 'thiobarbituric acid reacting substances' (TBARS). The change in the level of endogenous LDL alpha-tocopherol was also monitored simultaneously. The oxidisability of LDL isolated from OBJ patients was significantly higher and showed a steep increase in the level of conjugated diene formation without any lag phase. In normal samples the oxidation proceeded slowly with a lag phase. This was also evidenced by the level of formation of hydroperoxides and TBARS. The basal level of LDL alpha-tocopherol was significantly low in OBJ samples. UDCA was found to delay the oxidation of LDL in a dose dependent manner. The consumption of alpha-tocopherol was found to be minimum in the presence of UDCA. The results of this investigation show that there is a high susceptibility of LDL to oxidation in OBJ cases and this may be due to low endogenous LDL alpha-tocopherol content. UDCA minimizes LDL oxidation in dose dependent manner, which is an additional evidence for its antioxidant nature.

UI MeSH Term Description Entries
D008077 Lipoproteins, LDL A class of lipoproteins of small size (18-25 nm) and light (1.019-1.063 g/ml) particles with a core composed mainly of CHOLESTEROL ESTERS and smaller amounts of TRIGLYCERIDES. The surface monolayer consists mostly of PHOSPHOLIPIDS, a single copy of APOLIPOPROTEIN B-100, and free cholesterol molecules. The main LDL function is to transport cholesterol and cholesterol esters to extrahepatic tissues. Low-Density Lipoprotein,Low-Density Lipoproteins,beta-Lipoprotein,beta-Lipoproteins,LDL(1),LDL(2),LDL-1,LDL-2,LDL1,LDL2,Low-Density Lipoprotein 1,Low-Density Lipoprotein 2,LDL Lipoproteins,Lipoprotein, Low-Density,Lipoproteins, Low-Density,Low Density Lipoprotein,Low Density Lipoprotein 1,Low Density Lipoprotein 2,Low Density Lipoproteins,beta Lipoprotein,beta Lipoproteins
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010084 Oxidation-Reduction A chemical reaction in which an electron is transferred from one molecule to another. The electron-donating molecule is the reducing agent or reductant; the electron-accepting molecule is the oxidizing agent or oxidant. Reducing and oxidizing agents function as conjugate reductant-oxidant pairs or redox pairs (Lehninger, Principles of Biochemistry, 1982, p471). Redox,Oxidation Reduction
D002756 Cholagogues and Choleretics Gastrointestinal agents that stimulate the flow of bile into the duodenum (cholagogues) or stimulate the production of bile by the liver (choleretic). Choleretics,Cholagogues,Cholagogues, Choleretics,Choleretics and Cholagogues,Hydrocholeretics
D003300 Copper A heavy metal trace element with the atomic symbol Cu, atomic number 29, and atomic weight 63.55. Copper-63,Copper 63
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006861 Hydrogen Peroxide A strong oxidizing agent used in aqueous solution as a ripening agent, bleach, and topical anti-infective. It is relatively unstable and solutions deteriorate over time unless stabilized by the addition of acetanilide or similar organic materials. Hydrogen Peroxide (H2O2),Hydroperoxide,Oxydol,Perhydrol,Superoxol,Peroxide, Hydrogen
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

A Geetha, and R Surendran
January 2000, Research communications in molecular pathology and pharmacology,
A Geetha, and R Surendran
February 2003, The Journal of nutritional biochemistry,
A Geetha, and R Surendran
June 2021, Pharmaceuticals (Basel, Switzerland),
A Geetha, and R Surendran
February 1995, British journal of clinical pharmacology,
A Geetha, and R Surendran
May 1993, Biochemical Society transactions,
A Geetha, and R Surendran
January 2010, Indian journal of clinical biochemistry : IJCB,
A Geetha, and R Surendran
January 2009, Iranian biomedical journal,
Copied contents to your clipboard!